High-Cost Medicines: Access, Affordability, and Prices

Syed Shahzad Hasan; Chia Siang Kow; Zaheer-Ud-Din Babar

High-Cost Medicines: Access, Affordability, and Prices

Syed Shahzad Hasan, Chia Siang Kow, Zaheer-Ud-Din Babar

Research output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary › peer-review

Abstract

Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.

Original language	English
Title of host publication	Encyclopedia of Pharmacy Practice and Clinical Pharmacy
Editors	Zaheer Ud-Din Babar
Publisher	Elsevier
Pages	20-26
Number of pages	7
Volume	2
Edition	1
ISBN (Electronic)	9780128127360
ISBN (Print)	9780128127353
Publication status	Published - 20 Jun 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://www.sciencedirect.com/science/article/pii/B9780128127353003022Licence: Unspecified

Cite this

@inbook{5c99dd5f88e149909405e7e05fea7a7c,

title = "High-Cost Medicines: Access, Affordability, and Prices",

abstract = "Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.",

keywords = "Accessibility, Affordability, High-cost, Pricing, Reimbursement",

author = "Hasan, \{Syed Shahzad\} and Kow, \{Chia Siang\} and Zaheer-Ud-Din Babar",

year = "2019",

month = jun,

day = "20",

language = "English",

isbn = "9780128127353",

volume = "2",

pages = "20--26",

editor = "Babar, \{Zaheer Ud-Din\}",

booktitle = "Encyclopedia of Pharmacy Practice and Clinical Pharmacy",

publisher = "Elsevier",

address = "Netherlands",

edition = "1",

}

TY - CHAP

T1 - High-Cost Medicines

T2 - Access, Affordability, and Prices

AU - Hasan, Syed Shahzad

AU - Kow, Chia Siang

AU - Babar, Zaheer-Ud-Din

PY - 2019/6/20

Y1 - 2019/6/20

N2 - Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.

AB - Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.

KW - Accessibility

KW - Affordability

KW - High-cost

KW - Pricing

KW - Reimbursement

UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85079256285&origin=inward&txGid=ec1c58f4b8d4b32c3015fb9591e60388

M3 - Entry for encyclopedia/dictionary

SN - 9780128127353

VL - 2

SP - 20

EP - 26

BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy

A2 - Babar, Zaheer Ud-Din

PB - Elsevier

ER -

High-Cost Medicines: Access, Affordability, and Prices

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this